DP
Dechra Pharma
DPH.L·LSENorthwich UKFounded 19972,000 employees
Mid CappharmaPublicOncology
Platform: Vet Pharma
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (DPH.L)
Loading DPH.L stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemazanubrutinib | DPH-168 | Approved | 2 | AuroraA | WilmsMDD | ||
| DPH-273 | DPH-273 | NDA/BLA | 2 | BET | Wilms | ||
| Zanumavacamten | DPH-1933 | Phase 1/2 | 2 | DLL3 | DravetAS |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Dechra Pharma trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)